The US Food and Drug Administration has approved a test developed by Abbott Laboratories to detect antibodies to Trypanosoma cruzi, the cause of Chagas disease.
The US Food and Drug Administration has approved a test developed by Abbott Laboratories to detect antibodies to Trypanosoma cruzi, the cause of Chagas disease.
The Abbott ESA Chagas test is an in vitro enzyme strip assay that qualitatively identifies antibodies.
Karen Midthun, director of the FDA Center for Biologics Evaluation and Research, said that the test will help healthcare specialists to provide counselling to donors with positive screening test results.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Medical Device Network Excellence Awards - Nominations Closed
Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact
Excellence in Action SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.
